SARS-CoV-2 Variant Determination Through SNP Assays in Samples From Industry Workers From Rio de Janeiro, Brazil

Frontiers in Microbiology

Isadora Alonso Corrêa¹  Antonio Augusto Fidalgo-Neto²  Bruna Farjun³  Janaina de Barros Figueiredo³  Sergio Noboru Kuriyama³  Bianca Monteiro Henriques-Santos³ 

[1] Department of Virology, Paulo de Góes Institute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;SENAI Innovation Institute for Green Chemistry, Industry Federation of the State of Rio de Janeiro, Rio de Janeiro, Brazil;SESI Innovation Center for Occupational Health, Industry Federation of the State of Rio de Janeiro, Rio de Janeiro, Brazil;

关键词: SARS-CoV-2;    coronavirus;    variant;    Alpha;    Gamma;    Zeta;   

DOI  :  10.3389/fmicb.2021.757783

来源: DOAJ

【 摘 要 】

Since the first reported case in December 2019, SARS-CoV-2 infections have become a major public health worldwide. Even with the increasing vaccination in several countries and relaxing of social distancing measures, the pandemic remains a threat especially due to the emergence of new SARS-CoV-2 variants. Despite the presence of an enzyme capable of proofreading its genome, high rates of replication provide a source of accumulation of mutations within the viral genome. In this retrospective study, samples from a cohort of industry workers tested by the SESI’s COVID-19 mass testing program from September 2020 to May 2021 were analyzed using a mutation panel in order to describe the circulation of currently identified SARS-CoV-2 variants within the samples obtained in Rio de Janeiro State. Our results demonstrated that the variant of interest (VOI) Zeta has been in circulation since October 2020 and reached 87% of prevalence in February 2021 followed by a decrease due to the emergence of Gamma variant of concern (VOC). Gamma was detected in January 2021 in our studied population, and its prevalence increased during the following months, reaching absolute prevalence within positive samples in May. The Alpha variant was detected only in 4–7% of samples during March and April while Beta VOC was not detected in our study. Our data agree with sequencing genomic surveillance databases and highlight the importance of continuous mass testing programs and variant detection in order to control viral spread and guide public health measures.

【 授权许可】

Unknown